ArticleMicrobial cell factories2026
Metabolic engineering of Synechocystis sp. PCC 6803 for olivetolic acid production.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Olivetolic acid (OLA), the critical aromatic precursor for plant-derived cannabinoids, conventionally relies on resource-intensive plant extraction or complex chemical synthesis. This study establishes an environmentally friendly biosynthetic platform by genetically engineering the model cyanobacterium Synechocystis sp. PCC 6803. We constructed the heterologous OLA pathway by co-expressing plant-derived tetraketide synthase (TKS), olivetolic acid cyclase (OAC), and acyl-activating enzyme 1 (AAE1). Through cultivation supplemented with sodium hexanoate, successful biosynthesis of OLA was achieved within this photosynthetic host. To overcome metabolic bottlenecks, the pathway was further optimized using the robust P
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.